An unknown buyer signed a memorandum of understanding to acquire 43.41% stakes of Hybrigenics SA (ENXTPA:ALHYG) from Diagnostic Medical Systems S.A. (ENXTPA:ALDMS) on October 19, 2022. Diagnostic Medical Systems S.A will sale 116.911328 million Hybrigenics shares, representing 43.41% of the company's share capital.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.96 EUR | -5.42% | -6.34% | -15.42% |
04-18 | Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-09 | Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29% | MT |
1st Jan change | Capi. | |
---|---|---|
-15.42% | 18.22M | |
-4.01% | 14.91B | |
-35.44% | 2.96B | |
-14.59% | 2.41B | |
-11.01% | 1.48B | |
-.--% | 1.12B | |
+58.24% | 583M | |
+94.87% | 515M | |
+12.77% | 244M | |
+0.12% | 230M |
- Stock Market
- Equities
- ALDMS Stock
- News Diagnostic Medical Systems
- An unknown buyer signed a memorandum of understanding to acquire 43.41% stakes of Hybrigenics SA from Diagnostic Medical Systems S.A..